Amylase-Producing Primary Peritoneal Carcinoma.
10.3904/kjm.2015.89.3.358
- Author:
Ji Woon LEE
1
;
Sang Gon PARK
Author Information
1. Division of Hemato-Oncology, Department of Internal Medicine, Chosun University School of Medicine, Gwangju, Korea. sgpark@chosun.ac.kr
- Publication Type:Case Report
- Keywords:
Hyperamylasemia;
Peritoneal neoplasms;
Paraneoplastic syndromes
- MeSH:
Amylases;
Diagnosis;
Drug Therapy;
Humans;
Hyperamylasemia;
Korea;
Lung Neoplasms;
Multiple Myeloma;
Ovarian Neoplasms;
Paraneoplastic Syndromes;
Peritoneal Neoplasms
- From:Korean Journal of Medicine
2015;89(3):358-362
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
A paraneoplastic syndrome is a disease or symptom that is the consequence of the presence of cancer in the body but is not due to the local presence of cancer cells. Thus, successful treatment of the underlying tumor often improves such syndromes. Amylase-producing lung cancer, multiple myeloma, and ovarian cancer are reported only rarely. In Korea, no cases of hyperamylasemia have been reported in patients with primary peritoneal carcinoma. We report an interesting case of hyperamylasemia suspected to have been induced by primary peritoneal carcinoma. The patient's amylase isoenzyme patterns indicated salivary-type amylase. Hyperamylasemia was reduced in parallel with the response to chemotherapy. These data confirmed the diagnosis of amylase-producing primary peritoneal carcinoma.
